Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Buyers are here

<< Previous

Bullboard Posts

Next >>

Comment by jfm1330on Sep 06, 2023 2:56pm

217 Views

Post# 35622415

RE:RE:RE:RE:RE:RE:Buyers are here

Combining US and Canada, maybe 5 M shares will be traded today, that's 20 M shares pre reverse split. More than 20% of the total number of shares. Sure some day traders were involved today, so the same share could have changed hands several times today. Nonetheless, it is enormous volume.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"